OTD Home | OU Home | OUHSC Home | OU Tulsa Home
Office of Technology Development University of Oklahoma
from the lab to the market
spacer      ABOUT OTD       TECHNOLOGIES        INVENTORS        SPINOFF COMPANIES        IP FORMS       RELATED LINKS        SEARCH        CONTACT US

ANNOUNCEMENT: Equity Management Committee Meeting Scheduled for Nov. 7.

space


Synthetic Vitamin A retinoid compound effective against cancer, polycystic kidney disease
A synthetic Vitamin A retinoid compound that induces potent apoptosis, a natural form of cell suicide in cancer cells, but that, unlike current cancer therapies, is not toxic to healthy cells ... read more


Vitamin Retinoid
space
space
Inventor Highlight
 

Edgar O'Rear III

Tyrell Conway
Using cutting-edge technology called microarrays
read more about this inventor

Pereira
Edgar O'Rear
cotton fabric that is water repellent while still retaining its most desirable features
read more about this inventor



Featured Company

Selexys Pharmaceuticals Corp.

Selexys Pharmaceuticals Corp. is a privately held company that develops and commercializes therapeutics to treat inflammatory and thrombotic diseases.

The company has completed research and is in preclinical development of two drug candidates, a monoclonal antibody and a glycosulfopeptide, that have broad application for the treatment of acute and chronic inflammatory disorders.


Focus on Technology
spacer


Norman Campus
Three Partners Place
201 David L. Boren Blvd., Suite 100
Norman, Oklahoma 73019-5710
Tel: (405) 325-3800
Fax: (405) 325-7162

OU Health Sciences Center Campus
755 Research Parkway, Suite 429
Oklahoma City, OK 73104
Tel: (405) 271-7725
Fax: (405) 271-3555

bottom bar